Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Invested Capital (2020 - 2025)

Historic Invested Capital for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $218.5 million.

  • Bioventus' Invested Capital fell 305.86% to $218.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $218.5 million, marking a year-over-year decrease of 305.86%. This contributed to the annual value of $212.9 million for FY2024, which is 1446.9% down from last year.
  • Latest data reveals that Bioventus reported Invested Capital of $218.5 million as of Q3 2025, which was down 305.86% from $244.7 million recorded in Q2 2025.
  • Bioventus' 5-year Invested Capital high stood at $965.3 million for Q4 2021, and its period low was $212.9 million during Q4 2024.
  • Over the past 5 years, Bioventus' median Invested Capital value was $245.5 million (recorded in 2021), while the average stood at $349.1 million.
  • Per our database at Business Quant, Bioventus' Invested Capital soared by 50652.05% in 2021 and then crashed by 7001.45% in 2023.
  • Bioventus' Invested Capital (Quarter) stood at $965.3 million in 2021, then dropped by 13.99% to $830.3 million in 2022, then plummeted by 70.01% to $249.0 million in 2023, then decreased by 14.47% to $212.9 million in 2024, then grew by 2.61% to $218.5 million in 2025.
  • Its Invested Capital was $218.5 million in Q3 2025, compared to $244.7 million in Q2 2025 and $222.8 million in Q1 2025.